BNP Paribas Financial Markets’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-591
| Closed | -$6.83K | – | 3635 |
|
|
2020
Q2 | $6.83K | Sell |
591
-3,722
| -86% | -$43K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $59.1K | Buy |
4,313
+2,356
| +120% | +$32.3K | ﹤0.01% | 2853 |
|
|
2019
Q4 | $11.5K | Sell |
1,957
-165
| -8% | -$974 | ﹤0.01% | 3443 |
|
|
2019
Q3 | $11.2K | Buy |
2,122
+648
| +44% | +$3.44K | ﹤0.01% | 3488 |
|
|
2019
Q2 | $11.3K | Sell |
1,474
-1,252
| -46% | -$9.64K | ﹤0.01% | 3451 |
|
|
2019
Q1 | $54.3K | Buy |
2,726
+2,600
| +2,063% | +$51.7K | ﹤0.01% | 2869 |
|
|
2018
Q4 | $1.67K | Sell |
126
-509
| -80% | -$6.73K | ﹤0.01% | 3150 |
|
|
2018
Q3 | $23.3K | Buy |
635
+56
| +10% | +$2.06K | ﹤0.01% | 2686 |
|
|
2018
Q2 | $20.3K | Sell |
579
-1,354
| -70% | -$47.4K | ﹤0.01% | 2848 |
|
|
2018
Q1 | $89.9K | Buy |
1,933
+21
| +1% | +$976 | ﹤0.01% | 2667 |
|
|
2017
Q4 | $71.7K | Buy |
1,912
+747
| +64% | +$28K | ﹤0.01% | 2817 |
|
|
2017
Q3 | $62K | Buy |
1,165
+263
| +29% | +$14K | ﹤0.01% | 2599 |
|
|
2017
Q2 | $51.4K | Buy |
902
+811
| +891% | +$46.2K | ﹤0.01% | 2703 |
|
|
2017
Q1 | $4.9K | Sell |
91
-399
| -81% | -$21.5K | ﹤0.01% | 2769 |
|
|
2016
Q4 | $27.9K | Sell |
490
-87
| -15% | -$4.96K | ﹤0.01% | 2581 |
|
|
2016
Q3 | $35.9K | Buy |
577
+311
| +117% | +$19.3K | ﹤0.01% | 2582 |
|
|
2016
Q2 | $15.1K | Buy |
+266
| New | +$15.1K | ﹤0.01% | 2715 |
|
|
2016
Q1 | – | Sell |
-566
| Closed | -$79.7K | – | 3176 |
|
|
2015
Q4 | $79.7K | Buy |
566
+158
| +39% | +$22.2K | ﹤0.01% | 2485 |
|
|
2015
Q3 | $39.6K | Buy |
+408
| New | +$39.6K | ﹤0.01% | 3028 |
|